Nurix Therapeutics Inc.
NRIX | NASDAQ
$25.41
-$0.03 (-0.12%)
At close: Sep 21, 2026, 4:00 PM ET
$25.40
-$0.01 (-0.04%)
Pre-market:
Sep 22, 2026, 7:15 AM ET
Fiscal Quarter Period Ending | Q2 2026 May 30, 2026 | Q1 2026 Feb 27, 2026 | Q4 2025 Nov 29, 2025 | Q3 2025 Aug 30, 2025 | Q2 2025 May 30, 2025 | Q1 2025 Feb 27, 2025 | Q4 2024 Nov 29, 2024 | Q3 2024 Aug 30, 2024 | Q2 2024 May 30, 2024 | Q1 2024 Feb 28, 2024 | Q4 2023 Nov 29, 2023 | Q3 2023 Aug 30, 2023 | Q2 2023 May 30, 2023 | Q1 2023 Feb 27, 2023 | Q4 2022 Nov 29, 2022 | Q3 2022 Aug 30, 2022 | Q2 2022 May 30, 2022 | Q1 2022 Feb 27, 2022 | Q4 2021 Nov 29, 2021 | Q3 2021 Aug 30, 2021 | Q2 2021 May 30, 2021 | Q1 2021 Feb 27, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -89.54M | -87.17M | -78.22M | -86.42M | -43.46M | -56.35M | -58.55M | -48.96M | -44.55M | -41.52M | -41.96M | -36.98M | -24.28M | -40.73M | -46.72M | -45.71M | -45.4M | -42.53M | -37.7M | -28.84M | -26.38M | -24.28M |
Depreciation & Amortization | 3.85M | 3.78M | 4.63M | 5M | 5.1M | 4.13M | 4.3M | 4.15M | 4.09M | 3.89M | 3.76M | 3.38M | 3.33M | 3.18M | 3.04M | 2.89M | 2.63M | 2.25M | 4.05M | 745K | 645K | 643K |
Stock-Based Compensation | 11.39M | 9.4M | 9.09M | 9.77M | 10.39M | 8.72M | 8.51M | 8.75M | 8.85M | 7.82M | 8.02M | 8.45M | 8.72M | 8.48M | 8.3M | 6.99M | 6.78M | 6.07M | 4.84M | 4.31M | 3.94M | 2.7M |
Other Working Capital | -5.77M | 4.36M | -4.58M | 14.23M | -29.8M | -10.82M | -7.14M | -3.8M | -3.4M | -9.28M | 52.11M | -16.47M | -3.06M | -19.02M | -7.02M | -9.79M | 569K | -6.86M | -1.4M | -5.94M | -9.61M | 20.5M |
Other Non-Cash Items | -18.38M | -1.82M | -1.78M | -2.2M | -2.7M | -3.56M | -3.46M | -3.42M | -2.16M | -2.86M | 11.87M | -1.2M | -950K | -762K | -650K | 83K | 661K | 542K | 606K | 662K | 344K | 222K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 930K | -8.89M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -3.9M | 3.9M | -1.55M | 16.46M | -32.48M | -14.03M | 449K | -2.7M | -5.94M | -10.21M | 53.88M | -14.78M | -5.3M | -18.62M | -1.92M | -10.56M | 2.42M | -8.96M | -2.71M | -6.86M | -10.09M | 28.76M |
Operating Cash Flow | -96.57M | -71.91M | -67.83M | -57.39M | -63.16M | -61.09M | -48.75M | -42.18M | -39.71M | -41.95M | 26.69M | -41.13M | -18.47M | -48.45M | -37.96M | -46.31M | -32.91M | -42.63M | -30.91M | -29.97M | -31.54M | 8.05M |
Capital Expenditures | -1.94M | -1.05M | -5.13M | -2.71M | -2.68M | -3.49M | -2.11M | -2.35M | -1.94M | -2.88M | -2.59M | -2.46M | -1.08M | -2.28M | -2.57M | -3.42M | -2.79M | -3.47M | -862K | -1.87M | -2.09M | -843K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 38.4M | n/a | -38.4M | 88.49M | -25.23M | -44.91M | -18.35M | -57.57M | 59.66M | 1.98M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -24.63M | -255.93M | -174.34M | -103M | -68.17M | -110.18M | -298.22M | -129.82M | -225.12M | -54.8M | -88.39M | -74.59M | -60.71M | -22.64M | -26.91M | -132.42M | -64.79M | -15.25M | -90.68M | -74.58M | -135.5M | -47.74M |
Sales Maturities Of Investments | 119.56M | 133.15M | 179.82M | 156.19M | 142.34M | 139.2M | 159.5M | 110.83M | 95.99M | 93.2M | 76.61M | 99.82M | 105.62M | 40.99M | 84.48M | 72.77M | 62.81M | 58.75M | 55.02M | 64.21M | 80.48M | 46.2M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -38.4M | n/a | 38.4M | -88.49M | 25.23M | 44.91M | 18.35M | 57.57M | -59.66M | -1.98M | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 93M | -123.83M | 346K | 50.48M | 71.5M | 25.53M | -140.82M | -21.34M | -131.07M | 35.51M | -14.37M | 22.78M | 43.83M | 16.07M | 55.01M | -63.08M | -4.77M | 40.03M | -36.52M | -12.23M | -57.11M | -2.39M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 15K | -15K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | 1.45M | 3.9M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 96.01M | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 66K | 19.98M | 236.01M | 1.16M | 6K | 1.47M | 200.52M | 45.77M | 237.75M | 1.62M | 7K | 1.7M | 25K | 1.48M | -135K | 115.41M | 432K | 1.49M | 500K | 1.55M | 150.47M | 1.36M |
Net Cash Flow | -3.51M | -175.77M | 168.52M | -5.76M | 8.34M | -34.08M | 10.95M | -17.75M | 66.98M | -4.81M | 12.32M | -16.65M | 25.39M | -30.9M | 16.92M | 6.02M | -37.25M | -1.11M | -66.93M | -40.65M | 61.83M | 7.03M |
Free Cash Flow | -98.51M | -72.96M | -72.96M | -60.1M | -65.84M | -64.57M | -50.86M | -44.52M | -41.64M | -44.84M | 24.1M | -43.59M | -19.55M | -50.73M | -40.52M | -49.73M | -35.7M | -46.1M | -31.77M | -31.84M | -33.63M | 7.21M |
Adj. Free Cash Flow | -109.9M | -82.36M | -82.05M | -69.87M | -76.22M | -73.29M | -59.36M | -53.28M | -50.49M | -52.66M | 16.08M | -52.04M | -28.27M | -59.21M | -48.82M | -56.71M | -42.48M | -52.17M | -36.62M | -36.15M | -37.57M | 4.51M |
Maintenance CapEx | -1.94M | -1.05M | -4.93M | -2.71M | n/a | -2.18M | -2.11M | -2.35M | -1.94M | -654.53K | n/a | n/a | n/a | -719.97K | -2.57M | -3.17M | -830.65K | -1.39M | -616.6K | n/a | -1.08M | -97.78K |
Growth CapEx | n/a | n/a | -204.46K | n/a | -2.68M | -1.3M | n/a | n/a | n/a | -2.23M | -2.59M | -2.46M | -1.08M | -1.56M | n/a | -243.16K | -1.96M | -2.08M | -245.4K | -1.87M | -1.01M | -745.22K |
Owner Earnings | -98.51M | -72.96M | -72.76M | -60.1M | -63.16M | -63.27M | -50.86M | -44.52M | -41.64M | -42.61M | 26.69M | -41.13M | -18.47M | -49.17M | -40.52M | -49.48M | -33.74M | -44.02M | -31.53M | -29.97M | -32.62M | 7.96M |
Add to Watchlist
Select watchlists to add or remove NRIX